. We used bias ments where 10 M riluzole was applied alone (i.e., there was no effect on the mean frequency of respiratorycurrent to slowly adjust membrane potential from Ϫ70 to Ϫ40 mV and search for baseline membrane potentials related motor output and no additional decline in XIIn activity) (data not shown). The significance of these unthat might induce voltage-dependent intrinsic bursting. Slow continuous changes in bias current ( Figure 2D ), a expected results depends entirely on how riluzole affects pacemaker neurons.
series of small, step-like changes in bias current ( Figure  3A ), or slow, ramp-like commands ( Figure 3B ) were used. Without exception, bursting in preBö tC paceRiluzole Blocks Bursting Behavior in Pacemaker Neurons maker neurons was blocked by riluzole (n ϭ 2 at 1 M, n ϭ 45 at 10 M, and n ϭ 3 at 20 M). We recorded from pacemaker neurons to determine whether riluzole could prevent bursting via its selective
Figures 1-3 suggest that voltage-sensitive pacemaker neurons are not required to generate respiratory rhythm blockade of I NaP (Urbani and Belluzzi, 2000). Respiratory pacemaker neurons discharge in phase with XIIn motor in vitro. However, the strength of the conclusions that can be drawn from these results depends on whether rhythm (Figure 2A ) but can be distinguished from nonpacemaker neurons by depolarizing baseline membrane there are other potentially confounding effects of riluzole on respiratory neurons and the extent to which riluzole potential, which causes pacemakers to generate ectopic bursts during the intervals between XIIn motor output abolished pacemaker activity in the entire rhythm-generating network. (Figure 2B ). Ectopic bursts occur in the absence of network-mediated burst activity and, thus, reflect the intrinsic voltage-dependent burst-generating mechanism, Riluzole Effects on the Membrane Properties of Respiratory Neurons which is based on I NaP (Del Negro et al., 2001 ). We synaptically isolated ectopic burst-generating neurons using
To determine the effects of riluzole on I NaP in respiratory neurons, we synaptically isolated neurons using low low Ca 2ϩ (0.5 mM)/high-Mg 2ϩ (2 mM) artificial cerebro- 
Ca
2ϩ ACSF with 10 mM tetraethylammonium (TEA). We baseline membrane potential to peak) decreased in a dose-dependent manner: amplitude declined Յ8% at recorded Na ϩ currents in voltage-clamp with a Cs ϩ -based electrode solution (see Experimental Proceriluzole concentrations Յ20 M and declined no more than 31% at 200 M, the highest concentration tested. dures). I NaP was evoked by 20 mV/s descending (n ϭ 11) or ascending (n ϭ 4) ramp commands, which inactivate
The EC 50 was 38 M ( Figure 4D , closed circles, n ϭ 6). Spike threshold, rheobase, and action potential duration the fast Na ϩ current responsible for action potentials but do not completely inactivate I NaP . 20 M riluzole greatly also increased in a dose-dependent manner in the presence of riluzole ( Figure 4C , right). At 10 M, the standard reduced I NaP ( Figure 4A ). I NaP (obtained by subtraction) activated near Ϫ60 mV and peaked at approximately dose of riluzole to block pacemaker activity, spike threshold was generally 4 mV higher than control (see Ϫ20 mV (57 Ϯ 8 pA, n ϭ 11 at 20 M riluzole; Figure  4B ). Riluzole antagonized I NaP in a dose-dependent man- Figure 4C , open triangles). Action potentials were not blocked by riluzole at any concentration but were ner with an EC 50 of 3 M ( Figure 4D, open circles) .
Next, we examined the effects of riluzole on evoked blocked by 1 M tetrodotoxin (TTX, n ϭ 4; data not shown). action potentials. Spikes were triggered by 5 ms current steps (at rheobase) from a holding potential of Ϫ60 mV.
We investigated the effects of riluzole on the membrane properties and repetitive spiking capabilities of Figure 4C Figure 5C ), and spike amplitude did not decline as notably as in control. All of these effects ure 5A, n ϭ 11).
We then repeated the step-command protocols using are consistent with the selective blockade of a persistent inward current such as I NaP . bias current to adjust for riluzole-induced hyperpolarization and stabilize the baseline membrane potential. In control solution with neurons whose voltage was held at Statistical and Physiological Limits A definitive test of the pacemaker hypothesis requires hyperpolarized potentials below the activation threshold for I NaP (e.g., Ϫ66 mV in Figure 5B ), step commands that riluzole prevent voltage-dependent bursting in all the respiratory pacemaker neurons of the preBö tC. The evoked a spike train after a 150 ms "delayed excitation" that characterizes an important class of respiratory neucellular data above demonstrate that 100% of the pacemaker neurons we recorded (50/50 cells) depend on rons ("Type 1," Rekling et al., 1996). After applying 20 M riluzole, the characteristic delayed excitation and I NaP and lost their intrinsic bursting capabilities in the presence of riluzole (Յ20 M). These data agree with spike output were unchanged ( Figure 5B ). When membrane potential was held at more positive levels all previous reports, which also show that burst generation in preBö tC pacemaker cells depends predominantly (e.g., Ϫ55 mV in Figure 5C bursting could be restored in pacemaker cells in the For several values of x (3%, 4%, 5%, 6%, 10%, 15%, presence of riluzole by elevating the K ϩ concentration. and 20%) and n (10-200), we sampled repeatedly (Manly, After blocking bursting behavior with 10 M riluzole (in 1991) to determine the probability (p) of finding only low Ca 2ϩ ACSF), we increased the external K ϩ from 3 black balls (with Ն1000 trials for each value of x and to 9 mM but could not elicit voltage-dependent bursting n). Samples composed entirely of black balls became at any baseline membrane potential (n ϭ 6; data not progressively unlikely as x (the percentage of white balls) shown). and/or sample size (n) increased (Figure 6 ).
In our case with n ϭ 50, failing to discover a single riluzole-insensitive pacemaker neuron was statistically Discussion unlikely (p Ͻ 0.05) if these neurons comprised Ն6% of the total pacemaker cell population (Figure 6) . This staWe tested the pacemaker hypothesis using an in vitro mammalian model of neural generation of respiratory tistically significant upper limit of undetected pacemaker neurons (Ͻ6%) overestimates the likely physiological activity. Riluzole selectively blocked I NaP , the burst-generating current in preBö tC respiratory neurons, and, at upper limit, which may be 0%. -sensitive pacemaker cells would also be antagoincreases at Ն20 M riluzole; Figure 1B) . Therefore, the nized by appropriate doses of riluzole because the drug cellular properties blocked by riluzole may contribute suppresses both burst-generating currents I NaP and I Ca , to regular periodic network activity, even though they and blockade of either intrinsic current is sufficient to are not essential. Also, the area and the amplitude of the abolish bursting ( Was our sample size too small to substantiate a negative result? Based on our statistics, the sample size was amplitude, prolonged spike duration, and increased threshold voltage as its concentration increased up to sufficiently large enough that the probability of failing to find a single riluzole-insensitive pacemaker neuron 200 M (Figures 4C and 4D) . Aside from its effects on I NaP , riluzole also inhibits high-threshold Ca 2ϩ channels was less than 0.05, if such heretofore unseen neurons comprise Ն6% of the total pacemaker population. 
